369 related articles for article (PubMed ID: 36016629)
61. Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.
Ali R; Yang Y; Antkowiak M; Gabr A; Mora R; Abouchaleh N; Al Asadi A; Kulik L; Ganger D; Abecassis M; Kataraya N; Mulcahy M; Benson A; Mahalingam D; Thornburg B; Mouli S; Lewandowski RJ; Salem R; Riaz A
Cardiovasc Intervent Radiol; 2019 May; 42(5):700-711. PubMed ID: 30824946
[TBL] [Abstract][Full Text] [Related]
62. Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.
Yang J; Bao Y; Chen W; Duan Y; Sun D
Front Oncol; 2020; 10():551668. PubMed ID: 33163397
[TBL] [Abstract][Full Text] [Related]
63. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
64. Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization.
Liu Y; Shi M; Chen S; Wan W; Shen L; Shen B; Qi H; Cao F; Wu Y; Huang T; Chen G; Mo J; Ye D; Zhang Y; Feng Z; Fan W
J Cancer Res Ther; 2021 Jul; 17(3):740-748. PubMed ID: 34269308
[TBL] [Abstract][Full Text] [Related]
65. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
Zhang T; Liu Z; Zhao X; Mao Z; Bai L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437
[No Abstract] [Full Text] [Related]
66. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.
Halazun KJ; Rosenblatt RE; Mehta N; Lai Q; Hajifathalian K; Gorgen A; Brar G; Sasaki K; Doyle MBM; Tabrizian P; Agopian VG; Najjar M; Ivanics T; Samstein B; Brown RS; Emond JC; Yao F; Lerut J; Rossi M; Mennini G; Iesari S; Finkenstedt A; Schaefer B; Mittler J; Hoppe-Lotichius M; Quintini C; Aucejo F; Chapman W; Sapisochin G
JAMA Surg; 2021 Jun; 156(6):559-567. PubMed ID: 33950167
[TBL] [Abstract][Full Text] [Related]
67. A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis.
Feng LH; Zhu YY; Zhou JM; Wang M; Wang L; Xu WQ; Zhang T; Mao AR; Cong WM; Dong H; Wang L
Ann Surg Oncol; 2023 Jan; 30(1):363-372. PubMed ID: 36151430
[TBL] [Abstract][Full Text] [Related]
68. [Analysis of the diagnostic efficiency of combining multiple laboratory hematological indicators in alpha-fetoprotein-negative hepatocellular carcinoma].
Wang H; Dong J; Bao JF; Wang CB; Lyu JX
Zhonghua Yi Xue Za Zhi; 2022 May; 102(17):1303-1310. PubMed ID: 35488700
[No Abstract] [Full Text] [Related]
69. Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation.
Zhang L; Zhang X; Wu B; Han X; Guo C; Li B; Jing H; Cheng W
Pathol Oncol Res; 2023; 29():1611175. PubMed ID: 37325466
[No Abstract] [Full Text] [Related]
70. Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma.
Wei Z; Zhang Y; Lu H; Ying J; Zhao H; Cai J
Transl Cancer Res; 2022 Apr; 11(4):669-677. PubMed ID: 35571648
[TBL] [Abstract][Full Text] [Related]
71. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
[TBL] [Abstract][Full Text] [Related]
72. Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation.
Zhang BL; Liu J; Diao G; Chang J; Xue J; Huang Z; Zhao H; Yu L; Cai J
J Hepatocell Carcinoma; 2024; 11():489-508. PubMed ID: 38463544
[TBL] [Abstract][Full Text] [Related]
73. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
74. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.
Wu Z; Tang H; Wang L; Jin X; Lei Z; Yang P; Zhou J
BMC Surg; 2022 Mar; 22(1):103. PubMed ID: 35313836
[TBL] [Abstract][Full Text] [Related]
75. Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors.
Liu C; Zhao H; Zhang R; Guo Z; Wang P; Qu Z
Oncol Lett; 2023 Oct; 26(4):437. PubMed ID: 37664652
[TBL] [Abstract][Full Text] [Related]
76. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
[TBL] [Abstract][Full Text] [Related]
77. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
78. Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery.
Gao RQ; Sun JH; Ma YH; Xie YW; Shao GM; Wang C; Tan B; Liu K; Li K; Li N; Hu WY; Cao J
J Oncol; 2023; 2023():1875153. PubMed ID: 36873738
[TBL] [Abstract][Full Text] [Related]
79. Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
An SL; Xiao T; Wang LM; Rong WQ; Wu F; Feng L; Liu FQ; Tian F; Wu JX
Asian Pac J Cancer Prev; 2015; 16(10):4421-7. PubMed ID: 26028108
[TBL] [Abstract][Full Text] [Related]
80. Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.
Zhang H; Zhou Y; Li Y; Qin W; Zi Y; Liu Y; Qiu X; Xu H; Liao W; Huang Z
BMC Cancer; 2020 Feb; 20(1):132. PubMed ID: 32070301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]